PHOTOCURE: VISONAC® PHASE 2b TRIAL RESULTS - INVITATION TO PRESENTATION AND WEBCAST

Oslo, Norway, May 31, 2012: Photocure ASA (OSE: PHO), is pleased to announce the results of its Phase 2b study for Visonac, a novel topical treatment under development for moderate to severe acne. Photocure will host a presentation and webcast at 15.00 CET / 14.00 BST / 09.00 EST to present the results on Thursday 31^st May 2012.

WHERE:  Hotel Continental, Stortingsgaten 24/26, Oslo, Norway

SPEAKERS:

• Kjetil Hestdal, President & CEO, Photocure
• Dr. David Pariser, MD, Principal Investigator
• Grete Hogstad, Vice President Strategic Marketing, Photocure 
• Inger Ferner Heglund, VP Research & Development, Photocure 

You can access the webcast and presentation via www.photocure.com or directly through: http://webtv.hegnar.no/webcast.php?id=65542. For a replay of the webcast please go to www.photocure.com.

For further information, please contact:

Photocure
President & CEO Kjetil Hestdal
Tel: + 47 913 19 535, Email: kh@photocure.no

M: Communications
Mary Clark, Amber Bielecka, Hollie Vile
Tel: +44 207920 2361, Email: photocure@mcomgroup.com